… apixaban or dabigatran had lower risk of major bleeding … mortality seen in patients on
low-dose dabigatran might be due to … to directly compare (without warfarin as indirect comparator) …

… apixaban 5 mg, dabigatran 150 mg, and rivaroxaban 20 mg. Low dose was not defined for
warfarin … , our results for the comparative risk of bleeding could have been affected by residual …

… , low-dose apixaban was associated with a greater risk of stroke/SE and death without a
reduction in the bleeding rates. … Patients prescribed with either dabigatran or edoxaban were not …

… comparison separately: premenopausal (those < 50 years of age) and postmenopausal (those
> 50 years of age); DOAC dose (low dose: dabigatran 75 mg, rivaroxaban 10 mg, and …

… risk for nonfatal extracranial bleeding in the rivaroxaban group was increased relative to that
in the apixaban … glomerular filtration rate, weight, low-dose aspirin use, and other factors. In …

… Apixaban had lower bleeding risk compared with warfarin in … there was no difference in
bleeding between the 3 drugs in … We excluded patients taking dabigatran due to small number (n=…

… While another study from the United States showed higher risk of gastrointestinal bleeding
in the rivaroxaban group[23], our study yielded favorable result pointing toward reduction of …

… When patients receiving high-dose diltiazem treatment were directly compared with those
receiving low-dose treatment, the HR was 1.14 (95% CI, 1.02-1.26). There was no evidence of …

… prescription for apixaban, rivaroxaban, dabigatran, or edoxaban in the preceding 180 days.
… One study found a decreased risk for major bleeding with apixaban relative to rivaroxaban. It …

… new users of apixaban, rivaroxaban, and dabigatran to new users of warfarin in a national
… Bleeding rates were higher among low dose rivaroxaban users with an indication for dose …